Search
for
Sort by
Research 871–900 of 1000+
- Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents
- The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
- Systemic Therapies for Scarring and Non-scarring Alopecia
- Androgenetic Alopecia: a Review and Emerging Treatments
- Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”
- Dermatology Benefits of Licorice (Glycyrrhiza glabra L.): A Review of its Potential in Skin and Hair Disorders
- Androgenetic Alopecia in Polycystic Ovary Syndrome: A Cutaneous Marker of Systemic Metabo-inflammatory and Endocrine Dysfunction: A Narrative Review
- Physiology of Skin, Hair, and Nails as Differentiated by Sex and Age
- Assessment of adipokines, hormonal profile, lipid profile, and insulin resistance in patients with androgenetic alopecia
- Ancient botanicals and the skin: Defining dermatologic ethnophytoconvergence as a translational framework for pharmacognosy
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Lithium chloride-treated human umbilical cord mesenchymal stem cells-derived exsomes promote hair growth by regulating miR-146a-5p-wnt pathway
- Botulinum toxin therapy for androgenetic alopecia: From mechanistic insights to clinical applications
- Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain
- Abstracts from the 2024 WDS Forum - virtual option
- Androgenic Alopecia: Recent Understanding of the Androgenetic Receptor-Mediated Molecular Mechanisms and Current Pharmacotherapy
- Placental mRNA Expression of Neurokinin B Is Increased in PCOS Pregnancies with Female Offspring
- The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- 5 Alpha-Reductase Inhibitory Potential of Solanum nigrum Effective for Management of Alopecia
- Genetics and Epigenetics of Polycystic Ovary Syndrome
- Targeted immunotherapy for hair regrowth and regeneration
- Hair Growth Effect of DN106212 in C57BL/6 Mouse and Its Network Pharmacological Mechanism of Action
- Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries
- Association of Acne Tarda with Endocrinological Disorders
- Isolation and HPLC Quantitative Determination of 5α-Reductase Inhibitors from Tectona grandis L.f. Leaf Extract
- Clinical Observation of Polycystic Ovary Syndrome Treatment with Resveratrol
- Skin Manifestations of Rheumatological Diseases
- Hair Follicle Stem Cells and Hair Regeneration
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome